PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933276
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933276
The global veterinary diagnostics market is witnessing substantial growth due to the rising prevalence of animal diseases, increasing pet ownership, and enhanced government initiatives to curb zoonotic outbreaks. Veterinary diagnostics involve tests performed on blood, tissue, urine, or stool to detect diseases, antibodies, proteins, or overall health indicators in animals. With the growing adoption of companion and livestock animals, as well as the demand for early detection of diseases, the market is set to expand significantly.
According to Fortune Business Insights, the market was valued at USD 8.78 billion in 2025, expected to grow to USD 9.72 billion in 2026, and projected to reach USD 21.59 billion by 2034, exhibiting a CAGR of 10.50% from 2026 to 2034. North America dominated the market in 2025 with a 47.82% share, driven by high pet ownership, increased expenditure on animal healthcare, favorable reimbursement policies, and strategic expansions by leading players. The U.S. market is projected to reach USD 6.96 billion by 2032, supported by robust investments in veterinary services and laboratory infrastructure.
Market Drivers
Rising Prevalence of Veterinary Diseases: Growing outbreaks of livestock and companion animal diseases, including zoonotic conditions like West Nile virus, influenza, coronaviruses, salmonella, rabies, and Lyme disease, are driving demand for diagnostic solutions. Molecular and immunodiagnostic tests are increasingly used to detect complex conditions, thereby supporting market expansion.
Growing Pet Ownership and Spending on Pet Care: Pet adoption is increasing globally, particularly in nuclear families. In the U.S., 66.0% of households owned a pet in 2024. Owners are investing more in preventive and diagnostic care, further propelling market growth. Initiatives such as mobile diagnostic services, like PepiPets in August 2022, allow in-home testing, enhancing accessibility and adoption.
Government Support and Awareness Campaigns: Strategic government funding and grants enhance early detection capabilities. For example, in November 2023, the Michigan State University Veterinary Diagnostic Laboratory received USDA funding to strengthen early detection of emerging animal diseases in the Midwest region. Such initiatives support market growth across North America and globally.
Market Restraints
Shortage of Skilled Veterinary Professionals: The scarcity of trained and qualified veterinarians limits the adoption of advanced diagnostic technologies, particularly in emerging markets. Studies indicate that approximately 41,000 veterinarians will be needed in the U.S. by 2030 to meet pet care demands. Additionally, inadequate training and insufficient laboratory staff hinder testing efficiency, restricting market expansion.
Market Segmentation
By Product Type:
By Technique:
By Animal Type:
By End User:
North America: Market size USD 4.2 billion in 2025, projected at USD 4.17 billion by 2026, driven by high pet ownership, expenditure on pet care, and strategic diagnostic lab expansions.
Europe: Strong market due to advanced healthcare infrastructure and strategic acquisitions. The UK is projected at USD 0.28 billion, Germany at USD 0.61 billion by 2026.
Asia Pacific: Fastest-growing region with Japan at USD 0.43 billion, China at USD 0.69 billion, and India at USD 0.19 billion by 2026, fueled by zoonotic disease awareness, increasing spending on pets, and veterinary workforce development initiatives.
Latin America & MEA: Growing at a moderate rate, supported by livestock population growth and awareness campaigns for diagnostic care.
Key Players & Industry Developments
Prominent companies include IDEXX Laboratories, Inc., Zoetis Services LLC, Heska Corporation, Thermo Fisher Scientific, Virbac, Randox Laboratories, Avante Animal Health, VCA Animal Hospitals, and Shenzhen Mindray Bio-Medical Electronics.
Recent Developments:
Conclusion
The global veterinary diagnostics market is projected to grow from USD 8.78 billion in 2025 to USD 9.72 billion in 2026, reaching USD 21.59 billion by 2034 at a CAGR of 10.50%. The market is driven by increasing pet ownership, rising prevalence of zoonotic and livestock diseases, advanced diagnostic technologies, and government support initiatives. Challenges such as shortage of skilled veterinary professionals and limited access to high-end diagnostics may restrain growth. Nevertheless, ongoing technological innovations, rising pet care expenditure, and strategic expansions by key players are expected to ensure robust growth and enhance global veterinary healthcare outcomes.
Segmentation By Product Type
By Technique
By Animal Type
By End User
By Region